These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21083458)

  • 21. Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice.
    Guo S; Casu C; Gardenghi S; Booten S; Aghajan M; Peralta R; Watt A; Freier S; Monia BP; Rivella S
    J Clin Invest; 2013 Apr; 123(4):1531-41. PubMed ID: 23524968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of hepcidin in iron metabolism.
    Nemeth E; Ganz T
    Acta Haematol; 2009; 122(2-3):78-86. PubMed ID: 19907144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.
    Gardenghi S; Ramos P; Marongiu MF; Melchiori L; Breda L; Guy E; Muirhead K; Rao N; Roy CN; Andrews NC; Nemeth E; Follenzi A; An X; Mohandas N; Ginzburg Y; Rachmilewitz EA; Giardina PJ; Grady RW; Rivella S
    J Clin Invest; 2010 Dec; 120(12):4466-77. PubMed ID: 21099112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Regulation of body iron homeostasis by hepcidin].
    Lipiński P; Starzyński RR
    Postepy Hig Med Dosw (Online); 2004 Mar; 58():65-73. PubMed ID: 15069380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of iron acquisition and iron distribution in mammals.
    Ganz T; Nemeth E
    Biochim Biophys Acta; 2006 Jul; 1763(7):690-9. PubMed ID: 16790283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein.
    Zhang AS; Anderson SA; Wang J; Yang F; DeMaster K; Ahmed R; Nizzi CP; Eisenstein RS; Tsukamoto H; Enns CA
    Blood; 2011 Feb; 117(5):1687-99. PubMed ID: 21115976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepcidin--a peptide hormone at the interface of innate immunity and iron metabolism.
    Ganz T
    Curr Top Microbiol Immunol; 2006; 306():183-98. PubMed ID: 16909922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron regulation and erythropoiesis.
    Nemeth E
    Curr Opin Hematol; 2008 May; 15(3):169-75. PubMed ID: 18391780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias.
    Nemeth E
    Adv Hematol; 2010; 2010():750643. PubMed ID: 20066043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Iron metabolism: State of the art].
    Beaumont C; Karim Z
    Rev Med Interne; 2013 Jan; 34(1):17-25. PubMed ID: 22595534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepcidin and its role in regulating systemic iron metabolism.
    Ganz T
    Hematology Am Soc Hematol Educ Program; 2006; ():29-35, 507. PubMed ID: 17124036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased hepcidin expression in murine β-thalassemia is associated with suppression of Bmp/Smad signaling.
    Parrow NL; Gardenghi S; Ramos P; Casu C; Grady RW; Anderson ER; Shah YM; Li H; Ginzburg YZ; Fleming RE; Rivella S
    Blood; 2012 Mar; 119(13):3187-9. PubMed ID: 22461476
    [No Abstract]   [Full Text] [Related]  

  • 33. Regulation of systemic iron homeostasis.
    Finberg KE
    Curr Opin Hematol; 2013 May; 20(3):208-14. PubMed ID: 23426198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.
    Gardenghi S; Grady RW; Rivella S
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1089-107. PubMed ID: 21075282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease.
    Fleming RE; Sly WS
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8160-2. PubMed ID: 11459944
    [No Abstract]   [Full Text] [Related]  

  • 36. Hereditary hemochromatosis.
    Pietrangelo A
    Annu Rev Nutr; 2006; 26():251-70. PubMed ID: 16848707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A tincture of hepcidin cures all: the potential for hepcidin therapeutics.
    Bartnikas TB; Fleming MD
    J Clin Invest; 2010 Dec; 120(12):4187-90. PubMed ID: 21099105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.
    Silvestri L; Pagani A; Nai A; De Domenico I; Kaplan J; Camaschella C
    Cell Metab; 2008 Dec; 8(6):502-11. PubMed ID: 18976966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation.
    Constante M; Jiang W; Wang D; Raymond VA; Bilodeau M; Santos MM
    Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G229-37. PubMed ID: 16565419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.
    Ginzburg Y; Rivella S
    Blood; 2011 Oct; 118(16):4321-30. PubMed ID: 21768301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.